Dr Reddy's Unleashes Obeda: Diabetes Drug with Ninja Prices!

Hey, believe it! Dr Reddy's Laboratories just dropped their new diabetes hero, Obeda, ready to take on the GLP-1 market in India! With a price cut of 62% compared to Ozempic, they're aiming to sell 12 million pens this year. This is just the start, and they're determined to be in the top five! Let's go, Team Obeda!